1. Scrip
  2. >>Business
  3. >>Deals

Remix Teams Up With Second Big Pharma With Roche Deal For RNA Technology

 
• By Alaric DeArment

The news comes just under two years after Remix signed a partnership with J&J, and the biotech announced the same-day closing of a $60m financing to develop its lead product candidate.

• Source: Shutterstock

Remix Therapeutics has added a second large pharma player to its list of partners in just under two years, while the partner, Roche Holding AG, has expanded its presence in the growing field of RNA-based therapeutics. Remix also scored a new venture capital infusion that it will devote toward clinical development of its lead product candidate in solid tumor and hematological oncology.

The Cambridge, MA-based biotech announced the deal with the Swiss drug maker and the close of a $60m financing on...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

Novartis Upbeat Even With Entresto Expiry Looming

 
• By Kevin Grogan

Swiss major confident that new oncology drugs will fill revenue gap.

China Sentences Astellas Employee To 3.5 Years In Prison On Spy Charges

 
• By Lisa Takagi

An employee of Astellas faces three and a half years in prison after sentencing by a court in China on espionage charges.

Sarepta Restructures, Cuts 500 Jobs As Elevidys-Related Deaths Impact Sales

 
• By Mandy Jackson

After a second quarter of declining Elevidys sales following two deaths of DMD patients treated with the gene therapy, Sarepta is cutting costs to fund remaining programs and meet debt requirements.